Serum Perilipin 2 (PLIN2) Predicts Multiple Organ Dysfunction in Critically Ill Patients

Area of Science:

• Biochemistry
• Critical Care Medicine
• Inflammation Research

Background:

• Perilipin 2 (PLIN2) is a lipid droplet protein with known metabolic roles.
• Limited research exists on PLIN2's involvement in systemic and acute inflammation.

Purpose of the Study:

• To investigate the significance of serum PLIN2 in critically ill patients.
• To determine if PLIN2 can serve as a biomarker for inflammation-related outcomes in intensive care.

Main Methods:

• Serum PLIN2 concentrations were measured in 259 critically ill patients (166 with sepsis) and 12 healthy controls upon ICU admission.
• Computed tomography was used to assess body composition in a subset of 36 patients.
• Statistical analyses were performed to correlate PLIN2 levels with clinical outcomes like multiple organ dysfunction (MOD) and mortality.

Main Results:

• Critically ill patients exhibited significantly higher serum PLIN2 levels compared to healthy controls.
• Serum PLIN2 independently indicated multiple organ dysfunction (MOD) at ICU admission (SOFA score > 9) and predicted MOD at 48 hours.
• Elevated PLIN2 levels were associated with severe respiratory failure, suggesting a potential link to critical illness severity.

Conclusions:

• This study demonstrates that serum PLIN2 is a novel indicator in critical illness, assisting in risk stratification.
• PLIN2 shows potential for independent prediction of multiple organ dysfunction in the ICU.
• Further research is needed to elucidate the specific mechanisms underlying PLIN2's role in critical illness and inflammation.